UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reply to: Supporting the case for a targeted approach for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del CFTR variant: further analysis for the French compassionate use programme

The European respiratory journal, 2024-02, Vol.63 (2), p.2400233

Burgel, Pierre-Régis

2024

Volltextzugriff (PDF)

What Do Adults With Cystic Fibrosis Want From Their Doctors?

Chest, 2022-12, Vol.162 (6), p.1225-1226

Burgel, Pierre-Régis

2022

Volltextzugriff (PDF)

The Changing Epidemiology of Cystic Fibrosis: The Implications for Adult Care

Chest, 2023-01, Vol.163 (1), p.89-99

2023

Volltextzugriff (PDF)

Cystic fibrosis in the era of CFTR modulators: did the neutrophil slip through the cracks?

Journal of leukocyte biology, 2024-02, Vol.115 (3), p.417-419

2024

Volltextzugriff (PDF)

Cast no shadow: assessing the disease-modifying effects of elexacaftor/tezacaftor/ivacaftor

The European respiratory journal, 2023-12, Vol.62 (6), p.2302026

2023

Volltextzugriff (PDF)

Future trends in cystic fibrosis demography in 34 European countries

The European respiratory journal, 2015-07, Vol.46 (1), p.133-141

2015

Volltextzugriff (PDF)

Inhaled therapy, cardiovascular risk and benefit-risk considerations in COPD: innocent until proven guilty, or vice versa ?

The European respiratory journal, 2023-02, Vol.61 (2), p.2202135

2023

Volltextzugriff (PDF)

Airway mucus accumulation in COPD: the cholinergic paradox

The European respiratory journal, 2020-01, Vol.55 (1), p.1902473

Burgel, Pierre-Régis

2020

Volltextzugriff (PDF)

Major Decrease in Lung Transplantation for Patients with Cystic Fibrosis in France

American journal of respiratory and critical care medicine, 2022-03, Vol.205 (5), p.584-586

2022

Volltextzugriff (PDF)

Cystic fibrosis transmembrane conductance regulator (CFTR): a missing link between smoking and chronic airway diseases?

The European respiratory journal, 2022-08, Vol.60 (2), p.2200898

2022

Volltextzugriff (PDF)

Diversity of approaches in artificial intelligence: an opportunity for discoveries in thoracic imaging

The European respiratory journal, 2022-07, Vol.60 (1), p.2200022

2022

Volltextzugriff (PDF)

Carriers of a single CFTR mutation are asymptomatic: an evolving dogma?

The European respiratory journal, 2020-09, Vol.56 (3), p.2002645

2020

Volltextzugriff (PDF)

Improved survival albeit with persistent disparities in prognosis for people with cystic fibrosis in European countries

The European respiratory journal, 2021-09, Vol.58 (3), p.2101487

2021

Volltextzugriff (PDF)

COVID-19 outcomes in people with cystic fibrosis

Current opinion in pulmonary medicine, 2021-11, Vol.27 (6), p.538-543

2021

Volltextzugriff (PDF)

Role of inhaled antibiotics in the era of highly effective CFTR modulators

European respiratory review, 2023-03, Vol.32 (167), p.220154

2023

Volltextzugriff (PDF)

"Can't Stop the Feeling": Symptoms as the Key to Trial Success in Bronchiectasis?

American journal of respiratory and critical care medicine, 2020-06, Vol.201 (12), p.1461-1462

2020

Volltextzugriff (PDF)

Do Cough and Sputum Production Predict COPD Exacerbations?: The Evidence Is Growing

Chest, 2019-10, Vol.156 (4), p.641-642

2019

Volltextzugriff (PDF)

Editorial: Real-world experience with CFTR modulator therapy

Frontiers in pharmacology, 2023-11, Vol.14, p.1331829-1331829

2023

Volltextzugriff (PDF)

CFTR Modulators: Current Status and Evolving Knowledge

Seminars in respiratory and critical care medicine, 2023-04, Vol.44 (2), p.186-195

2023

Volltextzugriff (PDF)

Cystic fibrosis

La Presse médicale (1983), 2023-09, Vol.52 (3), p.104169-104169, Article 104169

2023

Volltextzugriff (PDF)

Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality

PloS one, 2012-12, Vol.7 (12), p.e51048-e51048

2012

Volltextzugriff (PDF)

CT imaging shows specific pancreatic abnormalities in persons with cystic fibrosis related diabetes

Scientific reports, 2023-06, Vol.13 (1), p.10433-10433, Article 10433

2023

Volltextzugriff (PDF)

Targeting Mucus Hypersecretion: New Therapeutic Opportunities for COPD?

Drugs (New York, N.Y.), 2014-07, Vol.74 (10), p.1073-1089

2014

Volltextzugriff (PDF)

Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade

American journal of respiratory and critical care medicine, 2018-10, Vol.198 (7), p.928-940

2018

Volltextzugriff (PDF)

Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis

The European respiratory journal, 2017-08, Vol.50 (2), p.1700763-1700763

2017

Volltextzugriff (PDF)

1 – 25 von 256

Suche als RSS-Feed

Aktive Filter

ThemaHuman Health And Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(246)
Mit Volltextzugriff
(225)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(191)
Life Sciences & Biomedicine
(189)
Humans
(139)
Respiratory System
(137)
Cystic Fibrosis
(75)
Male
(63)
Female
(60)
Life Sciences
(50)
Adult
(48)
General & Internal Medicine
(36)
Chronic Obstructive Pulmonary Disease
(35)
Middle Aged
(31)
Critical Care Medicine
(27)
Cystic Fibrosis - Complications
(27)
Aged
(25)
Lung Diseases
(25)
Mortality
(23)
Risk Factors
(23)
Biological And Medical Sciences
(21)
Young Adult
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Reply to: Supporting the case for a targeted approach for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del CFTR variant: further analysis for the French compassionate use programme

What Do Adults With Cystic Fibrosis Want From Their Doctors?

The Changing Epidemiology of Cystic Fibrosis: The Implications for Adult Care

Cystic fibrosis in the era of CFTR modulators: did the neutrophil slip through the cracks?

Cast no shadow: assessing the disease-modifying effects of elexacaftor/tezacaftor/ivacaftor

Future trends in cystic fibrosis demography in 34 European countries

Inhaled therapy, cardiovascular risk and benefit-risk considerations in COPD: innocent until proven guilty, or vice versa ?

Airway mucus accumulation in COPD: the cholinergic paradox

Major Decrease in Lung Transplantation for Patients with Cystic Fibrosis in France

Cystic fibrosis transmembrane conductance regulator (CFTR): a missing link between smoking and chronic airway diseases?

Diversity of approaches in artificial intelligence: an opportunity for discoveries in thoracic imaging

Carriers of a single CFTR mutation are asymptomatic: an evolving dogma?

Improved survival albeit with persistent disparities in prognosis for people with cystic fibrosis in European countries

COVID-19 outcomes in people with cystic fibrosis

Role of inhaled antibiotics in the era of highly effective CFTR modulators

"Can't Stop the Feeling": Symptoms as the Key to Trial Success in Bronchiectasis?

Do Cough and Sputum Production Predict COPD Exacerbations?: The Evidence Is Growing

Editorial: Real-world experience with CFTR modulator therapy

CFTR Modulators: Current Status and Evolving Knowledge

Cystic fibrosis

Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality

CT imaging shows specific pancreatic abnormalities in persons with cystic fibrosis related diabetes

Targeting Mucus Hypersecretion: New Therapeutic Opportunities for COPD?

Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade

Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis

Aktive Filter

Suchergebnisse filtern